91 related articles for article (PubMed ID: 11901716)
1. Why MS nurses need to multiply.
Mulholland H
Nurs Times; 2002 Feb 14-20; 98(7):12-3. PubMed ID: 11901716
[No Abstract] [Full Text] [Related]
2. [Optimized compliance].
Krankenpfl J; 2005; 43(7-10):238. PubMed ID: 16515308
[No Abstract] [Full Text] [Related]
3. The challenges of measuring disability accumulation in relapsing-remitting multiple sclerosis: evidence from interferon beta treatments.
Kieseier BC
Expert Rev Neurother; 2014 Jan; 14(1):105-20. PubMed ID: 24417500
[TBL] [Abstract][Full Text] [Related]
4. Early interferon beta treatment in multiple sclerosis: nursing care implications of the BENEFIT study.
Webb UH
J Neurosci Nurs; 2008 Dec; 40(6):356-61. PubMed ID: 19170303
[TBL] [Abstract][Full Text] [Related]
5. NORdic trial of oral Methylprednisolone as add-on therapy to Interferon beta-1a for treatment of relapsing-remitting Multiple Sclerosis (NORMIMS study): a randomised, placebo-controlled trial.
Sorensen PS; Mellgren SI; Svenningsson A; Elovaara I; Frederiksen JL; Beiske AG; Myhr KM; Søgaard LV; Olsen IC; Sandberg-Wollheim M
Lancet Neurol; 2009 Jun; 8(6):519-29. PubMed ID: 19409854
[TBL] [Abstract][Full Text] [Related]
6. [MS patients should get beta-interferon therapy early and for a long time].
Ruutiainen J
Duodecim; 2001; 117(17):1693-5. PubMed ID: 12181931
[No Abstract] [Full Text] [Related]
7. Treatment of multiple sclerosis with human beta interferon.
Goodin DS
Int MS J; 2005 Nov; 12(3):96-108. PubMed ID: 16417818
[TBL] [Abstract][Full Text] [Related]
8. Interferons in relapsing remitting multiple sclerosis.
Rudick RA; Cookfair DL; Griffin J; Hauser S; Piantadosi S
Lancet; 2003 May; 361(9371):1824; author reply 1824-5. PubMed ID: 12781561
[No Abstract] [Full Text] [Related]
9. Interferons in relapsing remitting multiple sclerosis.
Freedman M; King J; Oger J; Sharief M; Hartung HP;
Lancet; 2003 May; 361(9371):1822-3; author reply 1823-4. PubMed ID: 12781558
[No Abstract] [Full Text] [Related]
10. Interferons in relapsing remitting multiple sclerosis.
Goodin DS
Lancet; 2003 May; 361(9371):1821; author reply 1823-4. PubMed ID: 12781556
[No Abstract] [Full Text] [Related]
11. Measuring and management of anti-interferon beta antibodies in subjects with multiple sclerosis.
Farrell RA; Giovannoni G
Mult Scler; 2007 Jun; 13(5):567-77. PubMed ID: 17548434
[TBL] [Abstract][Full Text] [Related]
12. Interferons in relapsing remitting multiple sclerosis.
Kappos L; Kesselring J
Lancet; 2003 May; 361(9371):1821-2; author reply 1823-4. PubMed ID: 12781557
[No Abstract] [Full Text] [Related]
13. Interferons in relapsing remitting multiple sclerosis.
Kolar OJ; Bauerle JA; Lee H
Lancet; 2003 May; 361(9371):1825. PubMed ID: 12781563
[No Abstract] [Full Text] [Related]
14. A randomized study of two interferon-beta treatments in relapsing-remitting multiple sclerosis.
Durelli L; Barbero P; Clerico M;
Neurology; 2006 Dec; 67(12):2264; author reply 2264-5. PubMed ID: 17190964
[No Abstract] [Full Text] [Related]
15. Interferons in relapsing remitting multiple sclerosis.
Paty D; Arnason B; Li D; Traboulsee A
Lancet; 2003 May; 361(9371):1822; author reply 1823-4. PubMed ID: 12781559
[No Abstract] [Full Text] [Related]
16. A randomized study of two interferon-beta treatments in relapsing-remitting multiple sclerosis.
Goodin DS
Neurology; 2006 Oct; 67(7):1313-4. PubMed ID: 17030783
[No Abstract] [Full Text] [Related]
17. Methylprednisolone in combination with interferon beta-1a for relapsing-remitting multiple sclerosis (MECOMBIN study): a multicentre, double-blind, randomised, placebo-controlled, parallel-group trial.
Ravnborg M; Sørensen PS; Andersson M; Celius EG; Jongen PJ; Elovaara I; Bartholomé E; Constantinescu CS; Beer K; Garde E; Sperling B
Lancet Neurol; 2010 Jul; 9(7):672-80. PubMed ID: 20542736
[TBL] [Abstract][Full Text] [Related]
18. Interferon-beta treatment and the natural history of relapsing-remitting multiple sclerosis.
Koch M; Mostert J; De Keyser J; Tremlett H; Filippini G
Ann Neurol; 2008 Jan; 63(1):125-6; author reply 126-7. PubMed ID: 17702024
[No Abstract] [Full Text] [Related]
19. Association between use of interferon beta and progression of disability in patients with relapsing-remitting multiple sclerosis.
Shirani A; Zhao Y; Karim ME; Evans C; Kingwell E; van der Kop ML; Oger J; Gustafson P; Petkau J; Tremlett H
JAMA; 2012 Jul; 308(3):247-56. PubMed ID: 22797642
[TBL] [Abstract][Full Text] [Related]
20. Azathioprine versus beta interferons for relapsing-remitting multiple sclerosis: a multicentre randomized non-inferiority trial.
Massacesi L; Tramacere I; Amoroso S; Battaglia MA; Benedetti MD; Filippini G; La Mantia L; Repice A; Solari A; Tedeschi G; Milanese C
PLoS One; 2014; 9(11):e113371. PubMed ID: 25402490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
